CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Proctitis

INFLAMMATION of the MUCOUS MEMBRANE of the RECTUM, the distal end of the large intestine (INTESTINE, LARGE).

Subtype terms (1)

More specific conditions that are subtypes of Proctitis in the MeSH hierarchy.

  • Proctocolitis

    2 drugs (1 approved, 1 experimental)

Drugs by status

Approved for this indication (1)

  • spectinomycin

Phase 4 trials (1)

  • sucralfate

Phase 3 trials (9)

  • maltodextrin
  • l-glutamine
  • mesalamine
  • hydrocortisone
  • fructo-oligosaccharide
  • budesonide
  • diosmetine
  • lactobacillus
  • bifidobacteria

Phase 2 trials (6)

  • thalidomide
  • niclosamide
  • hyaluronic acid
  • human fecal microbiota
  • autologous bone marrow derived mesenchymal cells
  • butyrate

Organizations

Organization Involved with Phase 4 Indications (5)

  • University of Adelaide
  • University of Queensland
  • Maria Sklodowska Curie Children's Hospital
  • University of New South Wales
  • University of Western Australia

Organization Involved with Phase 3 Indications (8)

  • Axcan
  • Bausch Health Companies
  • Servier
  • Sandoz
  • Cristcot LLC
  • University of London
  • Federal University of Mato Grosso do Sul
  • Medical University Innsbruck

Organization Involved with Phase 2 Indications (5)

  • Dr. Falk Pharma GmbH
  • University of Rome Tor Vergata
  • Evang. Krankenhaus Kalk
  • Sun Yat-Sen University
  • First Wave Bio, Inc.

ICD-10 crosswalk

  • K62.89 — Other specified diseases of anus and rectum

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.